Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease

Abroad (travel likely)Recruiting

Conditions

Nonalcoholic Fatty Liver Disease · Nonalcoholic Steatohepatitis · Fibrosis · HIV/AIDS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese Academy of Medical Sciences Peking Union Medical College Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (QING ZHANG) · 13207572893

Study leads

WEI Lyu
Principal Investigator
Department of Infectious Diseases, PekingUMCH

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Digoxin In NASH (CODIN)

NASH · NAFLD · MASH - Metabolic Dysfunction-Associated Steatohepatitis

Abroad (travel likely)RecruitingPHASE2

New Haven, United States · New Haven, United States

The European NAFLD Registry

NAFLD · NASH · NASH - Nonalcoholic Steatohepatitis

Abroad (travel likely)Recruiting

Antwerp, Belgium · Helsinki, Finland

Screening in Primary Care of Advanced Liver Fibrosis in NAFLD and/or Alcoholic Patients

Non-alcoholic Fatty Liver Disease (NAFLD) · Alcoholic Liver Disease (ALD) · Liver Fibrosis

Abroad (travel likely)Recruiting

Angers, France · Angers, France

Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis

Nonalcoholic Steatohepatitis

Abroad (travel likely)Recruiting

Rochester, United States · Richmond, United States